<table frame="void" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>TABLE IVLipid-lowering Effects of Lovastatin in Adolescent Boys with Heterozygous Familial Hypercholesterolemia(Mean Percent Change from Baseline at Week 48 in Intention-to-Treat Population)</caption>
<thead>
<tr><td align="left" valign="top">DOSAGE</td><td align="center" valign="top">N</td><td align="center" valign="top">TOTAL-C</td><td align="center" valign="top">LDL-C</td><td align="center" valign="top">HDL-C</td><td align="center" valign="top">TG.*</td><td align="center" valign="top">Apolipoprotein B</td></tr>
</thead>
<tfoot>
<tr><td align="left" colspan="7" valign="top">*data presented as median percent changes</td></tr>
</tfoot>
<tbody>
<tr><td align="left" valign="top">Placebo</td><td align="center" valign="top">61</td><td align="center" valign="top"> -1.1</td><td align="center" valign="top">-1.4</td><td align="center" valign="top">-2.2</td><td align="center" valign="top">-1.4</td><td align="center" valign="top">-4.4</td></tr>
<tr><td align="left" valign="top">Lovastatin </td><td align="center" valign="top">64</td><td align="center" valign="top">-19.3</td><td align="center" valign="top">-24.2</td><td align="center" valign="top">+1.1</td><td align="center" valign="top">-1.9</td><td align="center" valign="top">-21</td></tr>
</tbody>
</table>